GlassScriptPhysician profile
Ricky Y Ho
NPI 1962496794
$1,333.87
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970 · 2020: $364.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $401.78 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $176.53 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $139.08 | 2019-2020 | |
| Erbe USA INC | $130.50 | 2020 | |
| Janssen Biotech, INC. | $120.52 | 2019 | |
| Merck Sharp & Dohme LLC | $115.98 | 2019-2020 | |
| Daiichi Sankyo INC. | $54.56 | 2019 | |
| Ironwood Pharmaceuticals, INC | $44.29 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $37.31 | 2019 | |
| Gilead Sciences, INC. | $25.23 | 2019 | |
| Allergan, INC. | $24.00 | 2019 | |
| Pfizer INC. | $22.39 | 2019 | |
| Shionogi INC | $16.18 | 2019 | |
| Ucb, INC. | $13.97 | 2019 | |
| Romark Laboratories, Lc | $11.55 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricky Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.